Detalhe da pesquisa
1.
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.
Mol Cell
; 82(16): 3030-3044.e8, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764091
2.
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Mod Pathol
; 37(5): 100472, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492778
3.
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.
J Immunol
; 205(11): 3218-3229, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158953
4.
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
Am J Hematol
; 91(3): 277-82, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663264
5.
Survival outcomes and molecular drivers of testicular cancer in hispanic men.
Urol Oncol
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821727
6.
Kidney Cancer Updates from the 2023 American Society of Clinical Oncology Annual Meeting in Chicago.
Kidney Cancer J
; 21(2): 58-63, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298522
7.
Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma.
Kidney Cancer
; 7(1): 15, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999139
8.
Life-threatening hemoptysis in patients with metastatic kidney cancer.
Clin Genitourin Cancer
; 21(4): 497-506, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37045713
9.
Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
Urol Oncol
; 41(11): 460.e1-460.e9, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37709565
10.
Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
EClinicalMedicine
; 60: 102018, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37304495
11.
Extended disease control with unconventional cabozantinib dose increase in metastatic renal cell carcinoma.
Kidney Cancer
; 6(1): 69-79, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36743424
12.
Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma.
Clin Genitourin Cancer
; 20(3): 260-269, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277350
13.
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
Clin Cancer Res
; 28(22): 4907-4916, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074149
14.
Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.
Eur Urol
; 81(6): 555-558, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980496
15.
Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform.
Clin Cancer Res
; 27(17): 4794-4806, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210685
16.
A renal cell carcinoma tumorgraft platform to advance precision medicine.
Cell Rep
; 37(8): 110055, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818533
17.
The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities.
Cancer J
; 26(5): 390-398, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947307
18.
Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139246
19.
Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma.
Urol Oncol
; 37(12): 924-931, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522865
20.
Rucaparib for metastatic castration-resistant prostate cancer: did TRITON3 deliver a trifecta?
Transl Cancer Res
; 12(10): 2448-2453, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37969378